NASDAQ:HIMS

Hims & Hers (HIMS) stock slides in premarket on weak Q1 outlook as SEC probe comes into view

Hims & Hers (HIMS) stock slides in premarket on weak Q1 outlook as SEC probe comes into view

Hims & Hers Health Inc. shares dropped 6.8% to $14.46 in premarket trading Tuesday after its first-quarter revenue forecast missed analyst estimates. The company disclosed an SEC investigation into its statements about compounded semaglutide products and cited ongoing regulatory scrutiny. Investors await management’s next update on March 2.
February 24, 2026

Stock Market Today

  • Rio Tinto Group (LSE:RIO) Shares Seen 19.3% Overvalued Amid Strong Price Gains
    June 3, 2026, 5:59 AM EDT. Rio Tinto Group's shares (LSE:RIO) rose 3.2% in one day and 12.4% over the past month, continuing a 38.8% year-to-date gain. Despite recent momentum and trading near £83.08, analysts estimate a fair value of £69.66, indicating the stock is about 19.3% overvalued. The company's diversification into battery metals such as lithium and copper supports growth prospects linked to rising electric vehicle demand and energy storage needs. However, risks include potential weakness in iron ore and lithium prices, execution risks in new metals projects, and rising leverage. Rio Tinto's price-to-earnings ratio of 18.3x remains below sector averages, suggesting some market caution. Investors are advised to evaluate these mixed signals before deciding on potential upside or downside.